Website
VCID: 112145
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Small molecule therapeutics for neuromuscular and metabolic diseases. IPO in November 2006.Funding
Funding rounds
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
3i Group PLC | Major, long established, quoted private equity investor | United Kingdom |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
3i Group PLC Major, long established, quoted private equity investor |
N/A | |
|
Excalibur Fund Managers Ltd |
+44 (20) 7887-7642 |
N/A |
|
GIMV NV |
+32 (3) 290-2100 |
N/A |
|
NGN Capital LLC |
+1 (212) 972-0077 |
N/A |
|
Oxford Bioscience Partners III LP |
N/A |